The Standard Dental Labs Inc. (TUTH) SEC filings page on Stock Titan is designed to help investors and researchers review the company’s regulatory disclosures in one place. Standard Dental Labs is a Florida-based consolidator of independent dental laboratories, and its filings provide context on how it pursues acquisitions, structures its capital, and supports its roll-up strategy in the dental laboratory sector.
Although recent company communications highlight milestones such as SEC qualification of its Form 1-A Regulation A offering, name and ticker changes, and a reverse stock split, the detailed terms and risk factors associated with these actions are typically set out in formal SEC documents. On this page, users can access filings such as offering statements and related materials when they are available through the EDGAR system.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language. For lengthy documents, the platform highlights key topics such as acquisition structures, use of proceeds for purchasing additional dental laboratories in Florida, and descriptions of the company’s strategy to standardize digital workflows and centralize production. Where applicable, users can also review ownership and insider activity through forms that report share transactions by directors and significant shareholders.
Filings like annual and quarterly reports, when available, can provide additional detail on Standard Dental Labs’ acquisition pipeline, integration progress, and financial reporting related to its consolidation model. With real-time updates from EDGAR and AI-generated insights, this page offers a structured way to examine how TUTH describes its business, capital structure, and risks in official regulatory documents.
Standard Dental Labs Inc. (TUTH) reported six-month revenue of $342,634, compared with $163,261 in the prior-year period, and a net loss of $402,511 versus $424,347. On May 6, 2026, it closed the purchase of substantially all operating assets of BRLIT Dental Laboratory for stated total consideration of $900,000: $300,000 in cash and 1,200,000 restricted common shares valued at $600,000.
The $300,000 cash component includes $150,000 paid at closing and $150,000 payable 180 days after closing only if the acquired operation maintains at least 80% of its historical pro-rata revenue. The share consideration is held in escrow for release in eight equal quarterly installments, is subject to a 20% indemnity holdback for twelve months and may be reduced under a one-time earn-out if annual gross billings during the twelve months after closing fall below 80% of the seller’s target billings.
At June 30, 2026, cash was $13,169; the company used $437,222 in operating cash during the six months. It disclosed substantial doubt about its ability to continue as a going concern within one year after the statements are issued and said continued operations depend on additional capital, integrating acquired operations and achieving profitable operations.
Standard Dental Labs Inc. amended its previously disclosed Asset Purchase Agreement with Brlit Dental Laboratory, Inc. by filing Amendment No. 2 dated April 20, 2026 and Amendment No. 3 dated April 24, 2026. The report states those amendments "did not otherwise amend, alter or revise any of the terms and conditions" of the January 30, 2026 Asset Purchase Agreement as previously disclosed in the Company's Form 1-K filed April 9, 2026.
The Form 1-U is submitted under Regulation A and is signed by James D. Brooks, President.
Standard Dental Labs Inc. reported a private financing transaction involving a convertible note. On January 21, 2025, the company issued a convertible note with a principal amount of $200,000 to an existing investor, receiving $200,000 in cash proceeds.
Ninety days after issuance, the note’s principal plus any accrued and unpaid interest may be converted, at the holder’s option, into shares of the company’s common stock at a conversion price of $0.06 per share. The securities were issued in a private offering under Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.
Standard Dental Labs Inc. updated investors on its planned acquisition of certain assets from Dream Dentistry Labs, LLC. The company previously agreed to buy these assets for total consideration of $800,000, paid in a mix of cash and Standard Dental Labs common stock. On December 31, 2025, the parties signed an amendment extending the agreement’s end date from December 31, 2025 to January 7, 2026. The amendment did not change any other terms or conditions of the original asset purchase agreement.